Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | GFER | P55789 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.42 |
| ▸ | CASP6 | P55212 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | PRKDC | P78527 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2021224 | 0.87 | MAPT (0.66) | MAPTGAAALDH1A1GFERTSHR | |
| SCHEMBL11299225 | 0.83 | GAA (0.59) | MAPTGAAALDH1A1GFERTSHR | |
| SCHEMBL28747907 | 0.83 | MAPT (0.50) | MAPTGAAALDH1A1GFERTSHR | |
| SCHEMBL17801101 | 0.83 | USP2 (0.54) | MAPTGAAALDH1A1TSHRKDM4E | |
| SCHEMBL23244333 | 0.81 | ME2 (0.67) | MAPTALDH1A1GFERTSHRKDM4E | |
| SCHEMBL29577255 | 0.81 | ME2 (0.67) | MAPTALDH1A1GFERTSHRKDM4E | |
| SCHEMBL16695925 | 0.80 | MAPT (0.57) | MAPTGAAALDH1A1TSHRKDM4E | |
| SCHEMBL18470907 | 0.80 | TDP1 (0.52) | MAPTGAAALDH1A1LMNAHTT | |
| SCHEMBL10486194 | 0.79 | HPGD (0.51) | MAPTGAAALDH1A1GFERKDM4E | |
| SCHEMBL17807407 | 0.78 | ADRB1 (0.43) | MAPTGAAALDH1A1GFERKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230295133-A1 | PROCESS FOR PREPARING A COMPOUND USEFUL TO TREAT MYCOSES | PULMOCIDE LIMITED (GB) | 2023-09-21 | — | — | US | disclosed |
| CN-107635988-A | Antimycotic 4 (4 (4 (((3R, 5R) 5 ((1H 1,2, the base of 4 triazole 1) methyl) 5 (2,4 difluorophenyl) tetrahydrofuran, 3 base) methoxyl group) 3 aminomethyl phenyls) 1 base of piperazine) N (2 hydroxy-cyclohexyl) benzamides or its officinal salt | 普尔莫赛德有限公司 | 2018-01-26 | — | — | CN | disclosed |
| EP-3227277-A1 | ANTIMYCOTIC COMPOUND | Pulmocide Limited (GB) | 2017-10-11 | — | — | EP | disclosed |
| EP-3227278-A1 | ANTIMYCOTIC COMPOUND | Pulmocide Limited (GB) | 2017-10-11 | — | — | EP | disclosed |
| WO-2016087878-A1 | ANTIMYCOTIC COMPOUND | PULMOCIDE LIMITED (GB) | 2016-06-09 | — | — | WO | disclosed |
| WO-2016087880-A1 | ANTIMYCOTIC COMPOUND | PULMOCIDE LIMITED (GB) | 2016-06-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295133-A1 | PROCESS FOR PREPARING A COMPOUND USEFUL TO TREAT MYCOSES | DPM1, CYP51A1, ERG28 | MAPT 2626/4885GAA 71/4885ALDH1A1 2345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.